Posted: 20 August 2026 - Chapel Hill, United States of America
The University of North Carolina at Chapel Hill is seeking a Post-Doc Research Associate to investigate the tumor-intrinsic NLRP3 inflammasome's role in immune evasion related to tumor dormancy and treatment resistance. The successful candidate will conduct ex vivo tumor-T cell co-culture assays, utilize in vivo tumor models, and analyze tumor clinical specimens using techniques such as CRISPR/Cas9 gene deletion, flow cytometry, and RNA sequencing. A PhD is required, and experience with mouse tumor models and flow cytometry is preferred. This role is crucial for advancing knowledge in cancer research and contributes to the university's commitment to research excellence.